Tropicamide NDC 70069-121

NDC codes

FDA NDC Directory

Product NDC (as listed)70069-121Labeler and product segments. Claims need a package NDC.

Product NDC at billing width70069-0121Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
70069-121-01	70069012101	1 BOTTLE in 1 CARTON (70069-121-01) / 15 mL in 1 BOTTLEMarketed from Dec 12, 2019

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Tropicamide
Generic name (nonproprietary): tropicamide
Active ingredients: Tropicamide — 10 mg/mL
Dosage form: Solution/ drops
Route: Ophthalmic
Labeler: Somerset Therapeutics, LLC
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 207524
Marketing start: Dec 12, 2019
Listing expires: Dec 31, 2027
Other FDA classes: Cholinergic Antagonists (Mechanism)
Identifiers: Product ID 70069-121_43c4d1f7-c795-4100-b8c1-c6fd7d0ad624SPL ID 43c4d1f7-c795-4100-b8c1-c6fd7d0ad624SPL set ID 378b5fe2-4b5d-4c87-a7d6-fd0caa6402afRxCUI 314238UNII N0A3Z5XTC6UPC 0370069121016
Pharmacologic class: Anticholinergic

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Ophthalmic products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N470069012101 followed by a unit qualifier and the quantity

Package 70069-0121-01. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Apr 10, 2026.

Indications (excerpt from the label)

INDICATIONS AND USAGE For mydriasis and cycloplegia for diagnostic procedures.

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

Other NDCs under ANDA 207524

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 207524
Product	Strength	Form · route	Labeler	Product NDC
Tropicamide	Tropicamide 10 mg/mL	Solution/ dropsOphthalmic	Sportpharm LLC	85766-040